{"version":"1.0","provider_name":"Ultimate Health Report","provider_url":"https:\/\/ultimatehealthreport.com","author_name":"ultimatehealthreport","author_url":"https:\/\/ultimatehealthreport.com\/author\/ultimatehealthreport\/","title":"Centene sells Magellan RX to Prime Therapeutics for $1.35B","type":"rich","width":600,"height":338,"html":"
Centene sells Magellan RX to Prime Therapeutics for $1.35B<\/a><\/blockquote>